Financials
- Market Capitalization 3.82 B
- Employee 1 184
- Founded 2015
- CEO Christian Behrenbruch
- Website www.telixpharma.com
- Headquarter Australia
- FIGI BBG01N69K900
- Industry Biotecnologia
Receita total
Lucro líquido
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Related tickers
| # | Nome | Preços | 24h % | 7d % | 1M % | 1A % | Capitalização de mercado | Últimos 7 dias | |
|---|---|---|---|---|---|---|---|---|---|
| 1534 | AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 34.74 USD | -6.56% | -10.09% | +76.43% | +277.61% | 3.87 B USD | ||
| 1542 | DNLI Denali Therapeutics Inc. - Common Stock | 24.00 USD | -2.72% | -3.54% | 0.00% | +48.42% | 3.84 B USD | ||
| 1558 | VKTX Viking Therapeutics, Inc. - Common Stock | 32.16 USD | -5.02% | -4.63% | -4.06% | +19.24% | 3.75 B USD | ||
| 1563 | RCUS Arcus Biosciences, Inc. Common Stock | 29.19 USD | -4.61% | -4.30% | +6.46% | +176.42% | 3.72 B USD |